Investing.com - Amarin (NASDAQ:AMRN) reported on Wednesday second quarter earnings that missed analysts' forecasts and revenue that topped expectations.
Amarin announced earnings per share of $-0.09 on revenue of $94.4M. Analysts polled by Investing.com anticipated EPS of $-0.0648 on revenue of $87.62M.
Amarin shares are down 60.53% from the beginning of the year, still down 77.72% from its 52 week high of $5.97 set on August 23, 2021. They are under-performing the Nasdaq which is down 21.07% from the start of the year.
Amarin follows other major Healthcare sector earnings this month
Amarin's report follows an earnings beat by UnitedHealth on July 15, who reported EPS of $5.57 on revenue of $80.33B, compared to forecasts EPS of $5.21 on revenue of $79.68B.
J&J had beat expectations on July 19 with second quarter EPS of $2.59 on revenue of $24.02B, compared to forecast for EPS of $2.54 on revenue of $23.77B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar